Study on Gynecological Rare Cancers (MITO9B)

National Cancer Institute, Naples

Status: Enrolling

Conditions: Gynecologic Cancer

Treatments: Other: chemotherapy, surgery

Study type: Observational

Funder types: Other

Identifiers

NCT05733806

MITO 9B

Details and patient eligibility

About

This is a prospective, observational, multicenter study on gynecological rare tumors.

Full description

This is a prospective registry aimed to better understand prognosis, clinical and pathological features, management of this rare cancer conditions for improving standard of care.

Enrollment: 500 estimated patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• rare gynecological malignancies
• written informed consent
• patient fit for follow-up

Exclusion criteria

-written informed consent not provided

Trial design

500 participants in 1 patient group

Gynecologic rare tumors

Description:

The study will include patients with rare gynecologic malignancies

Treatment:

Other: chemotherapy, surgery